Bruce Weiller, Phd

RealSeq develops groundbreaking RNA fragmentomics technology to allow real-time detection of disease dramatically improving diagnosis and treatment. RiboMarkers are next generation cell free (cf)RNA fragmentomics-based diagnostics that are dynamic reporters able to predict dissemination of disease. We are developing and commercializing a liquid biopsy platform for debilitating fungal pathogens such as Valley Fever that are currently poorly managed yet rapidly increasing due to factors such as climate change with global implications. Our core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction, targeted NGS tools, and cf-RNA analysis (liquid biopsy).

Chemical Angels is a network of accredited investors. We invest our own capital into Chemistry enabled companies. Please see the Chemical Angels Network (LinkedIn Group) for interactive discussions and announcements. We serve the investor and the entrepreneur by presenting quality investment opportunities to qualified investors. Our mission is to provide financial capital and experienced mentorship to early stage chemical companies. Companies can submit applications for funding and investors can apply for membership at www.ChemicalAngels.com

RealSeq develops groundbreaking RNA fragmentomics technology to allow real-time detection of disease dramatically improving diagnosis and treatment. RiboMarkers are next generation cell free (cf)RNA fragmentomics-based diagnostics that are dynamic reporters able to predict dissemination of disease. We are developing and commercializing a liquid biopsy platform for debilitating fungal pathogens such as Valley Fever that are currently poorly managed yet rapidly increasing due to factors such as climate change with global implications. Our core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction, targeted NGS tools, and cf-RNA analysis (liquid biopsy).

Founded in San Diego, CA, NuFund is one of the largest, most active and most successful early-stage investor groups over the past 20+ years. We represent diverse backgrounds and perspectives, and work together to foster a culture of excellence, respect, innovation, and fun.

Founded as Tech Coast Angels in 1997, Tech Coast Angels Venture Group (TCA VG) has invested approximately $300 million in more than 525 companies, attracting an additional $2.2 billion in capital. With 400+ accredited investors in TCA LA, TCA OC, TCA Inland Empire, Pasadena Angels, and MEDA Angels, TCA VG is a key seed and early-stage funding source. Members, including founders and business leaders, deliver more than capital — providing counsel, mentorship, and access to extensive networks.

Chemical Angels is a network of accredited investors. We invest our own capital into Chemistry enabled companies. Please see the Chemical Angels Network (LinkedIn Group) for interactive discussions and announcements. We serve the investor and the entrepreneur by presenting quality investment opportunities to qualified investors. Our mission is to provide financial capital and experienced mentorship to early stage chemical companies. Companies can submit applications for funding and investors can apply for membership at www.ChemicalAngels.com